Effect of rhGH and rhIGF-I treatment on protein utilization in elderly women

American Journal of Physiology - Endocrinology and Metabolism

Volumn 272, Issue 1 35-1, 1997, Pages

  Butterfield, G E ^a   Thompson, J ^b   Rennie, M J ^b   Marcus, R ^b   Hintz, R L ^b   Hoffman, A R ^b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

aging; in vivo muscle protein synthesis; nitrogen balance; protein turnover; recombinant human growth hormone; recombinant human insulin like growth factor I; 1 13C leucine; 15N glycine

Indexed keywords

CARBON 13; GLYCINE; HUMAN GROWTH HORMONE; LEUCINE; NITROGEN 15; PROTEIN; RECOMBINANT SOMATOMEDIN C;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MUSCLE METABOLISM; NITROGEN BALANCE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS;

EID: 0031030941     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.272.1.e94     Document Type: Article

References (34)

1. Association of Analytical Chemists. Official Methods and Analyses (10th ed.). Washington, DC: Assoc. Analytical Chemists, 1965, p. 15.
2. Butterfield, G. E. Whole body protein utilization in humans. Med. Sci. Sports Exercise 19: 157-171, 1987.
3. Calloway, D. H. Nitrogen balance in men on marginal energy intakes. J. Nutr. 105: 914-923, 1975.
4. Calloway, D. H., A. C. O'Dell, and S. Margen. Sweat and miscellaneous nitrogen losses in human balance studies. J. Nutr. 101: 775-786, 1971.
5. Clemmons, D. R., A. Smith-Banks, and L. E. Underwood. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J. Clin. Endocrinol. Metab. 75: 234-238, 1992.
6. Clemmons, D. R., R. Williams, D. K. Snyder, and, L. E. Underwood. Treatment with growth hormone conserves lean body mass during dietary restriction in obese volunteers. J. Clin. Endocrinol. Metab. 64: 878-883, 1987.
7. Elahi, D., M. McAloon-Dyke, N. K. Fukagawa, A. L. Slater, G. A. Wong, R. S. Shannon, K. L. Minaker, J. M. Miles, A. H. Rubenstein, C. G. Vandepol, H.-P. Guler, W. R. Good, J. J. Seaman, and R. R. Wolfe. Effects of recombinant human IGF-I on glucose and leucine kinetics in men. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E831-E838, 1993.
8. Forbes, G. B. The adult decline in lean body mass. Hum. Biol. 48: 161-73, 1976.
9. Fryburg, D. A. Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism. Am. J. Physiol. 267 (Endocrinol. Metab. 30): E331-E336, 1994.
10. Fryburg, D. A., and E. J. Barrett. Growth hormone acutely stimulates skeletal muscle but not whole-body protein synthesis in humans. Metab. Clin. Exp. 42: 1223-1227, 1993.
11. Ghiron, L. J., J. L. Thompson, L. Holloway, R. L. Hintz, G. E. Butterfield, A. R. Hoffman, and R. Marcus. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women. J. Bone Miner. Res. 10: 1844-1852, 1995.
12. Guler, H.-P., J. Zapf, and E. R. Froesch. Short term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N. Engl. J. Med. 317: 137-140, 1987.
13. Haymond, M. W., F. F. Hober, P. DeFeo, S. E. Kahn, and N. Mauras. Effect of human growth hormone and insulin-like growth factor I on whole body leucine and estimates of protein metabolism. Horm. Res. 40: 92-94, 1993.
14. Hoffman, A. R., R. Marcus, R. L. Hintz, G. E. Butterfield, J. Thompson, L. Ghiron, S. Lieberman, E. Dall'Aglio, and G. P. Ceda. Effects of recombinant human insulin-like growth factor I in aging. In: GHRH, GH, and IGF-I. edited by M. R. Blackman, S. M. Harmon, J. Roth and J. R. Shapiro. Norwell, MA: Springer-Verlag, 1995, p. 266-276.
15. Holloway, L., G. Butterfield, R. L. Hintz, N. Gesundheit, and R. Marcus. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J. Clin. Endocrinol. Metab. 79: 470-479, 1994.
16. Horbor, F. F., and M. W. Haymond. Low dose recombinant human insulin-like growth factor I fails to affect protein anabolic side effects of prednisone in humans. J. Clin. Invest. 86: 265-272, 1990.
17. Hussain, M. A., O. Schmitz, A. Mengel, A. Keller, J. S. Christensen, J. Zapf, and E. R. Froesch. Insulin-like growth factor-I stimulates lipid oxidation, reduces protein oxidation and enhances insulin sensitivity in humans. J. Clin. Invest. 92: 2249-2256, 1993.
18. Kupfer, S. R., L. E. Underwood, R. D. Baxter, and D. R. Clemmons. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by the use of both agents simultaneously. J. Clin. Invest. 91: 391-396, 1993.
19. Laager, R., R. Ninnis, and U. Keller. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin in glucose and leucine kinetics in humans. J. Clin. Invest. 92: 1903-1909, 1993.
20. Lieberman, S. A., G. E. Butterfield, D. Harrison, and A. J. Hoffman. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 78: 404-410, 1994.
21. Lundeberg, S., M. Belfrage, J. Wernermon, A. Vonder Decker, S. Thunell, and E. Vinnars. Growth hormone improves muscle protein metabolism and whole body nitrogen economy in man during a hyponitrogenous diet. Metab. Clin. Exp. 40: 315-322, 1991.
22. Marcus, R., G. Butterfield, L. Holloway, L. Gilliland, D. J. Baylink, R. L. Hintz, and B. M. Sherman. Effects of short term administration of recombinant human growth hormone to elderly people. J. Clin. Endocrinol. Metab. 70: 519-527, 1990.
23. Mauras, N., F. F. Horber, and M. W. Haymond. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans. J. Clin. Endocrinol. Metab. 75: 1192-1197, 1992.
24. Metropolitan Life Insurance Company. 1979 Build Study. Soc. Actuaries Assoc. Life Ins. Med. Dir. Am., 1980.
25. Picou, D., and T. Taylor-Roberts. The measurement of total protein synthesis and catabolism and nitrogen turnover in infants in different nutritional states and receiving different amounts of dietary protein. Clin. Sci. 36: 283-296, 1969.
26. Richelsen, B., S. B. Pedersen, J. D. Børglum, T. Møller-Pedersen, J. Jørgensen, and J. O. Jørgensen. Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity. Am. J. Physiol. 266 (Endocrinol Metab. 29): E211-E216, 1994.
27. Rudman, D., A. B. Feller, H. S. Nagraj, G. A. Gergans, P. Y. Lalitha, A. F. Goldberg, R. A. Schlenker, L. Cohn, I. W. Rudman, and D. E. Mattson. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323: 1-6, 1990.
28. Russell-Jones, D. L., A. M. Umpleby, T. R. Hennessy, S. B. Bowes, F. Shojaee-Moradie, K. D. Hopkins, N. C. Jackson, J. M. Kelly, R. H. Jones, and P. H. Sonksen. Use of a leucine clamp to demonstrate that IGF-I activity stimulates protein synthesis in normal humans. Am. J. Phyisol. 267 (Endocrinol. Metab. 30): E591-E598, 1994.
29. 13C]valine. Am. J. Physiol. 262 (Endocrinol. Metab. 25): E372-E376, 1993.
30. Snyder, D. K., D. R. Clemmons, and L. E. Underwood. Treatement of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition. J. Clin. Endocrinol. Metab. 67: 54-61, 1988.
31. Taaffe, D. R., L. Pruitt, J. Reim, R. L. Hintz, G. Butterfield, A. R. Hoffman, and R. Marcus. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J. Clin. Endocrinol. Metab. 79: 1361-1366, 1994.
32. Thomas, J. R., and J. K. Nelson. Research Methods in Physical Activity (2nd ed.). Champaign, IL: Human Kinetics, 1990.
33. Thompson, J. L., G. E. Butterfield, R. Marcus, R. L. Hintz, M. Van Loan, L. Gihron, and A. R. Hoffman. The effects of recombinant human insulin like growth factor-I and growth hormone on body composition in elderly women. J. Clin. Endocrinol. Metab. 80: 1845-1852, 1995.
34. Yarasheski, K. E., J. A. Campbell, K. Smith, M. J. Rennie, J. O. Holloszy, and D. M. Bier. Effect of growth hormone and resistance exercise on muscle growth in young men. Am. J. Physiol. 262 (Endocrinol. Metab. 25): E261-E267, 1992.